Market Closed -
Nyse
01:30:02 25/06/2024 am IST
|
5-day change
|
1st Jan Change
|
23.34
USD
|
+0.82%
|
|
-0.64%
|
-12.39%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
825.8
|
1,049
|
1,114
|
855
|
694.3
|
614.3
|
-
|
-
|
Enterprise Value (EV)
1 |
1,018
|
1,259
|
1,380
|
1,208
|
1,098
|
1,100
|
1,158
|
1,217
|
P/E ratio
|
116
x
|
58.9
x
|
54.3
x
|
44.2
x
|
133
x
|
37.6
x
|
30.7
x
|
26.5
x
|
Yield
|
3.84%
|
3.58%
|
3.67%
|
4.93%
|
6.78%
|
7.93%
|
8.1%
|
8.27%
|
Capitalization / Revenue
|
13.6
x
|
13.9
x
|
12.3
x
|
8.75
x
|
6.15
x
|
4.96
x
|
4.51
x
|
3.94
x
|
EV / Revenue
|
16.7
x
|
16.6
x
|
15.2
x
|
12.4
x
|
9.73
x
|
8.89
x
|
8.5
x
|
7.8
x
|
EV / EBITDA
|
24.9
x
|
23.6
x
|
21.8
x
|
18.2
x
|
16.9
x
|
12.2
x
|
11.6
x
|
-
|
EV / FCF
|
-
|
14,76,27,274
x
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
0%
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
19,268
|
22,265
|
23,567
|
23,883
|
26,061
|
26,321
|
-
|
-
|
Reference price
2 |
42.86
|
47.11
|
47.27
|
35.80
|
26.64
|
23.34
|
23.34
|
23.34
|
Announcement Date
|
25/02/20
|
16/02/21
|
15/02/22
|
14/02/23
|
13/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
60.85
|
75.68
|
90.58
|
97.68
|
112.8
|
123.8
|
136.3
|
156
|
EBITDA
1 |
40.9
|
53.3
|
63.36
|
66.27
|
64.79
|
90.5
|
99.6
|
-
|
EBIT
1 |
18.67
|
27.92
|
32.91
|
33.87
|
25.1
|
38.27
|
44.02
|
52.9
|
Operating Margin
|
30.68%
|
36.9%
|
36.33%
|
34.67%
|
22.24%
|
30.91%
|
32.29%
|
33.91%
|
Earnings before Tax (EBT)
1 |
-
|
-
|
-
|
-
|
8.02
|
15.31
|
17.4
|
19.54
|
Net income
1 |
8.376
|
19.08
|
22.49
|
22.02
|
7.714
|
16.27
|
18.56
|
24.78
|
Net margin
|
13.77%
|
25.21%
|
24.83%
|
22.54%
|
6.84%
|
13.14%
|
13.61%
|
15.89%
|
EPS
2 |
0.3700
|
0.8000
|
0.8700
|
0.8100
|
0.2000
|
0.6200
|
0.7600
|
0.8800
|
Free Cash Flow
|
-
|
8.527
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
11.27%
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
16%
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
44.7%
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
1.645
|
1.685
|
1.735
|
1.765
|
1.805
|
1.850
|
1.890
|
1.930
|
Announcement Date
|
25/02/20
|
16/02/21
|
15/02/22
|
14/02/23
|
13/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
23.24
|
23.48
|
24.05
|
24.81
|
25.34
|
27.18
|
27.81
|
28.74
|
29.12
|
29.33
|
30.59
|
31.52
|
32.28
|
32.94
|
33.77
|
EBITDA
1 |
16.55
|
16.08
|
16.43
|
16.72
|
17.04
|
6.123
|
19.99
|
19.66
|
-
|
18.99
|
22.5
|
23.03
|
23.56
|
24.1
|
24.63
|
EBIT
1 |
8.727
|
8.132
|
8.3
|
8.715
|
8.72
|
-2.92
|
10.02
|
8.453
|
9.55
|
8.726
|
9.418
|
9.87
|
10.25
|
10.66
|
11.38
|
Operating Margin
|
37.55%
|
34.63%
|
34.51%
|
35.13%
|
34.41%
|
-10.74%
|
36.02%
|
29.42%
|
32.79%
|
29.75%
|
30.78%
|
31.32%
|
31.77%
|
32.35%
|
33.71%
|
Earnings before Tax (EBT)
1 |
-
|
-
|
5.6
|
-
|
-
|
-6.887
|
6.627
|
3.713
|
4.567
|
3.665
|
3.746
|
3.832
|
4.07
|
3.901
|
4.362
|
Net income
1 |
6.113
|
5.524
|
5.584
|
5.673
|
5.238
|
-6.922
|
6.577
|
3.492
|
4.567
|
3.665
|
3.99
|
4.15
|
4.45
|
4.36
|
4.594
|
Net margin
|
26.3%
|
23.53%
|
23.22%
|
22.87%
|
20.67%
|
-25.47%
|
23.65%
|
12.15%
|
15.68%
|
12.49%
|
13.04%
|
13.17%
|
13.79%
|
13.24%
|
13.6%
|
EPS
2 |
0.2300
|
0.2100
|
0.2100
|
0.2100
|
0.1900
|
-0.3200
|
0.2400
|
0.1100
|
0.1500
|
0.1100
|
0.1500
|
0.1600
|
0.1700
|
0.1800
|
0.1900
|
Dividend per Share
2 |
0.4375
|
0.4400
|
0.4400
|
0.4425
|
0.4450
|
0.4475
|
0.4500
|
0.4525
|
0.4550
|
-
|
0.4600
|
0.4600
|
0.4700
|
0.4700
|
0.4700
|
Announcement Date
|
15/02/22
|
03/05/22
|
02/08/22
|
01/11/22
|
14/02/23
|
02/05/23
|
01/08/23
|
31/10/23
|
13/02/24
|
30/04/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
193
|
210
|
266
|
353
|
403
|
486
|
544
|
603
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
4.707
x
|
3.938
x
|
4.192
x
|
5.326
x
|
6.224
x
|
5.37
x
|
5.462
x
|
-
|
Free Cash Flow
|
-
|
8.53
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
|
-
|
7
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
9.24%
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
25/02/20
|
16/02/21
|
15/02/22
|
14/02/23
|
13/02/24
|
-
|
-
|
-
|
Last Close Price
23.34
USD Average target price
28.83
USD Spread / Average Target +23.54% Consensus |
1st Jan change
|
Capi.
|
---|
| -12.39% | 614M | | +14.20% | 61.57B | | +1.71% | 20.48B | | -0.76% | 13.83B | | +9.59% | 8.3B | | -5.86% | 6.19B | | +11.89% | 3.62B | | +4.84% | 3.46B | | -8.64% | 2.97B | | +20.54% | 2.92B |
Healthcare REITs
|